Skip to Content

CannLabs Inc CANL

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CANL is trading at a 37% discount.
Price
$0.00
Fair Value
$9.95
Uncertainty
Extreme
1-Star Price
$3.94
5-Star Price
$2.28
Economic Moat
Jbp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CANL is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.10
Market Cap
$68,894.54
Volume/Avg
14,482 / 173,166

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

CannLabs Inc is based in Houston Texas and is a diversified inventory blockchain platform company. The company also has an entertainment division which also includes ownership of a Private Label Apparel line (Colorblind). The company is involved in four sectors: Manufacturing, Apparel, Music, and Video Game Design.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
37

Valuation

Metric
CANL
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
CANL
Quick Ratio
0.08
Current Ratio
0.09
Interest Coverage
−47.67
Quick Ratio
CANL

Profitability

Metric
CANL
Return on Assets (Normalized)
−409.72%
Return on Equity (Normalized)
−1,979.05%
Return on Invested Capital (Normalized)
−1,028.13%
Return on Assets
CANL
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ABlnlw$90.0 Bil
MKKGY
Merck KGaA ADRTxppljr$73.9 Bil
HLN
Haleon PLC ADRVdk$38.1 Bil
VTRS
Viatris IncGqdhm$16.0 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRMfsvk$14.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRHtjjn$12.8 Bil
CTLT
Catalent IncJnfpnvz$10.6 Bil
PRGO
Perrigo Co PLCNdzn$4.3 Bil
CURLF
Curaleaf Holdings IncTkr$3.8 Bil
PBH
Prestige Consumer Healthcare IncSrbgjf$3.4 Bil

Sponsor Center